Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
01 1Polfa Tarchomin
02 1Antibiotice SA
03 3Ascent Innovative Medicines
04 38Associated Biotech
05 1Astam Healthcare
06 7Atabay Group of Companies
07 3Avva Rus JSC
08 17Brooks laboratories Limited
09 1DEVATS INDIA
10 6DEVATS INDIA PRIVATE LTD
11 2Darou Pakhsh Pharma Chem Co
12 2Dr Seidel Life Science
13 1Embiotic Laboratories
14 1Flagship Biotech International Pvt. Ltd
15 3Hanlim Pharmaceutical
16 5Health Biotech
17 2IBN Savio
18 1InterMed
19 1KRUX Pharma
20 1Leeford Healthcare
21 23Medicef Pharma
22 2Myungmoon Pharm. Co., LTD.
23 7Neopharma
24 11Nishchem International Pvt. Ltd
25 1Orofino Pharmaceuticals Group
26 14Qualite Pharma
27 2RELIANCE FORMULATION PVT. LTD
28 2Smith & Kenner Pharmaceuticals
29 1Symbiosis Pharma
30 10Themis Medicare
31 4Unichem Laboratories Limited
32 1Vaishali Pharma Ltd
33 2World Medicine
34 2ZRS LABS
35 11Blank
01 1Amoxicillin Anhydrous; Clavulanic Acid
02 2Amoxicillin Sodium; Clavulanic Acid
03 2Amoxicillin Trihydrate; Clavulanate Potassium
04 87Amoxicillin Trihydrate; Clavulanic Acid
05 1Amoxicillin; CLAVULANIC ACID POTASSIUM
06 14Amoxicillin; Clavulanate Potassium
07 35Amoxicillin; Clavulanic Acid
08 1Amoxycillin Trihydrate; Potassium Clavulanate
09 3Amoxycillin; Clavulanic Acid
10 1Amoxycillin; Potassium Clavulanate
11 2Cefadroxil; Clavulanic Acid
12 2Cefixime; Clavulanate Potassium
13 8Cefixime; Clavulanic Acid
14 6Cefpodoxime Proxetil; Clavulanate Potassium
15 7Cefpodoxime Proxetil; Clavulanic Acid
16 1Cefpodoxime; Clavulanic Acid
17 10Cefuroxime Axetil; Clavulanic Acid
18 4Clavulanic Acid
19 3Ticarcillin; Clavulanic Acid
01 8Dispersible Tablet
02 2Drops
03 5Dry Powder Injectable
04 6Dry Syrup
05 1ER Tablet
06 5FC Tablet
07 2FILM COATED TABLET
08 11Film Coated Tablet
09 1Film Tablet
10 1Film-coated Tablet; Film-coated Tablet
11 1FilmTablet
12 6Injection
13 10OS
14 8Oral Suspension
15 2POWDER
16 1Pediatric Powder for Oral Suspension
17 4Powder for Oral Solution
18 7Powder for Oral Suspension
19 1Reconstituted syrup
20 1SYRUP
21 12Sachet
22 20Suspension
23 4TABLET
24 68Tablet
25 1Tablets
26 1Vial
27 1powder for injection/Infusion
01 11.2GM; 1.2GM
02 11.7GM; 10ML
03 2100 MG ; 62.50 MG
04 21000MG
05 41000MG; 125MG
06 21000MG; 200MG
07 21000MG; 62.5MG
08 2100MG; 12.5MG
09 4100MG; 62.5MG
10 21125MG
11 1125MG
12 1125MG/5ML; 31.25MG/5ML
13 2125MG; 31.25MG
14 1125MG; 31.5MG
15 1150MG; 150MG
16 1156.25MG
17 21:1
18 2200 MG ; 125 MG
19 1200 MG ; 28.50 MG
20 1200MG/5ML; 28.5MG/5ML
21 8200MG; 125MG
22 8200MG; 28.5MG
23 1228.5MG
24 1228.5MG; 5ML
25 2250 MG ; 125 MG
26 1250 MG ; 150 MG
27 1250 MG ; 62.50 MG
28 1250MG
29 1250MG/5ML; 62.5MG/5ML
30 10250MG; 125MG
31 3250MG; 31.25MG
32 1250MG; 31.5MG
33 4250MG; 62.5MG
34 128.5MG/5ML
35 13.1GM; 3.1GM
36 13.7G/30ML
37 1300MG; 300MG
38 1312.5MG
39 1375MG
40 13G; 100MG
41 1400MG/5ML; 57MG/5ML
42 9400MG; 57MG
43 140MG/ML; 5.7MG/ML
44 1437.5MG; 62.5MG
45 14500MG
46 1457MG
47 5500 MG ; 125 MG
48 1500MG
49 20500MG; 125MG
50 6500MG; 62.5MG
51 250MG; 12.5MG
52 250MG; 31.25MG
53 2562.5MG
54 1600MG/5ML; 42.9MG/5ML
55 2600MG; 42.9MG
56 1600MG; 600MG
57 2625MG
58 1800MG; 57MG
59 280MG; 11.4MG
60 1875 MG ; 125 MG
61 18875MG; 125MG
62 26Blank
01 2Germany
02 157India
03 2Iran
04 3Italy
05 1Poland
06 1Romania
07 3Russia
08 5South Korea
09 9Turkey
10 7U.A.E
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Amoxicillin Trihydrate; Clavulanic Acid
Brand Name :
Dosage Form : Powder for Oral Suspen...
Dosage Strength : 600MG; 42.9MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q3 2024
Amoxicillin Trihydrate; Clavulanic Acid
Dosage : Powder for Oral Suspen...
Dosage Strength : 600MG; 42.9MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Regulatory Info : Generic
Registration Country : Iran
Brand Name :
Dosage Form : POWDER
Dosage Strength : 1:1
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Iran
Packaging :
Regulatory Info : Generic
Dosage : POWDER
Dosage Strength : 1:1
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info : Generic
Registration Country : Iran
Brand Name :
Dosage Form : POWDER
Dosage Strength : 1:1
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Iran
Packaging :
Regulatory Info : Generic
Dosage : POWDER
Dosage Strength : 1:1
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Injection
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : TABLET
Dosage Strength : 250MG; 125MG
Packaging : 80T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 80T
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 250MG; 125MG
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : TABLET
Dosage Strength : 500MG; 125MG
Packaging : 40T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 40T
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 500MG; 125MG
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : SYRUP
Dosage Strength : 40MG/ML; 5.7MG/ML
Packaging : 50ml,10BTL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 50ml,10BTL
Regulatory Info : Generic
Dosage : SYRUP
Dosage Strength : 40MG/ML; 5.7MG/ML
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic B.E study
Registration Country : South Korea
Brand Name : Amoclan Duo
Dosage Form : TABLET
Dosage Strength : 437.5MG; 62.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic B.E study
Registration Country : South Korea
Packaging :
Regulatory Info : Generic B.E study
Dosage : TABLET
Dosage Strength : 437.5MG; 62.5MG
Brand Name : Amoclan Duo
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic B.E study
Registration Country : South Korea
Brand Name : Amoclan
Dosage Form : TABLET
Dosage Strength : 250MG; 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic B.E study
Registration Country : South Korea
Packaging :
Regulatory Info : Generic B.E study
Dosage : TABLET
Dosage Strength : 250MG; 125MG
Brand Name : Amoclan
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Brand Name :
Dosage Form : Suspension
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Packaging :
Regulatory Info : Generic ACTD Dossier- Available
Dosage : Suspension
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : India
